Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending July 27, 2024 (Week 30)
Reporting Area Gonorrhea §
Current weekPrevious 52 weeks Max †Cum YTD 2024 †Cum YTD 2023 †
U.S. Residents, excluding U.S. Territories 4,687 13,092 268,178 343,923
New England 11 435 5,686 9,188
Connecticut - 114 - 2,385
Maine 6 25 352 318
Massachusetts - 244 4,484 5,317
New Hampshire - 26 199 343
Rhode Island - 212 564 696
Vermont 5 8 87 129
Middle Atlantic 1,062 1,789 39,017 41,532
New Jersey 154 249 4,886 5,663
New York (excluding New York City) 271 319 6,843 7,539
New York City 373 836 17,174 17,660
Pennsylvania 264 413 10,114 10,670
East North Central 501 1,681 30,292 43,989
Illinois 8 577 5,421 14,041
Indiana 74 232 4,699 5,840
Michigan 61 383 6,860 8,698
Ohio 218 440 9,404 11,481
Wisconsin 140 169 3,908 3,929
West North Central 143 763 15,558 19,753
Iowa 56 87 1,779 2,193
Kansas 38 102 1,862 2,476
Minnesota 36 192 3,955 4,281
Missouri - 296 5,446 7,436
Nebraska 13 72 1,119 1,283
North Dakota - 35 394 703
South Dakota - 59 1,003 1,381
South Atlantic 1,167 4,665 74,846 85,825
Delaware 26 54 809 888
District of Columbia 15 140 2,969 3,154
Florida 551 2,716 24,079 26,846
Georgia 107 655 15,680 17,843
Maryland 2 301 5,484 6,884
North Carolina - 571 11,107 15,256
South Carolina 203 301 6,597 6,836
Virginia 263 328 7,742 7,587
West Virginia - 28 379 531
East South Central 349 888 10,462 22,461
Alabama 173 250 5,117 6,961
Kentucky 136 223 2,702 3,140
Mississippi 40 293 2,643 4,417
Tennessee - 369 - 7,943
West South Central 264 1,700 35,684 46,500
Arkansas 53 131 2,678 3,523
Louisiana 129 314 5,987 7,735
Oklahoma 23 165 2,046 4,229
Texas 59 1,167 24,973 31,013
Mountain 165 831 16,042 20,647
Arizona 18 330 7,175 8,055
Colorado - 242 3,348 4,184
Idaho 9 22 297 515
Montana 9 27 405 482
Nevada 92 166 2,324 3,634
New Mexico 5 95 1,243 2,067
Utah 32 71 1,150 1,559
Wyoming - 9 100 151
Pacific 1,025 2,035 40,591 54,028
Alaska 31 65 1,221 1,325
California 758 1,635 32,430 42,777
Hawaii - 52 - 1,014
Oregon 79 133 2,375 2,923
Washington 157 245 4,565 5,989
U.S. Territories - 34 37 653
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 34 37 653
U.S. Virgin Islands - 0 - -
Non-U.S. Residents - 4 8 11
Total 4,687 13,118 268,223 344,587
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2023 and 2024 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2023, confirmed and probable cases only are being published to align with the approved CSTE position statement 22-ID-03, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.